Streetbeat News

Stock Prices

SSKN

Strata Skin Sciences (SSKN) is highlighted as a strong choice for value investors due to its recent momentum and reasonable pricing. It has been identified through a 'Fast-Paced Momentum at a Bargain' screen.

Portfolio Pulse from

January 06, 2025 | 3:15 pm

STM

STMicroelectronics experienced a significant 50% drop in 2024 due to inventory corrections and valuation concerns. However, its strong market position and innovative products could offer opportunities in 2025.

Portfolio Pulse from

January 06, 2025 | 3:15 pm

AZN

AstraZeneca's stock has declined by nearly 14% over the past three months. Despite this, the company's key drugs, including Lynparza, Tagrisso, Imfinzi, Ultomiris, and Fasenra, are expected to drive sales. Additionally, AstraZeneca has several candidates with blockbuster potential.

Portfolio Pulse from

January 06, 2025 | 3:15 pm

GPRO

GoPro's stock has dropped 65% over the past year due to weak sales in both online and retail channels. Despite this, a stable subscriber base provides some support for the company.

Portfolio Pulse from

January 06, 2025 | 3:15 pm

PACS

Levi & Korsinsky has announced a class action lawsuit against PACS Group, Inc. with a lead plaintiff deadline of January 13, 2025. Investors who suffered losses are encouraged to seek potential recovery under federal securities laws.

Portfolio Pulse from

January 06, 2025 | 3:15 pm

CMG

A class action lawsuit has been filed against Chipotle Mexican Grill, Inc. (NYSE:CMG) for investors who suffered losses. Investors are encouraged to join the suit to potentially recover losses under federal securities laws.

Portfolio Pulse from

January 06, 2025 | 3:15 pm

SOND

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of Sonder Holdings Inc. (SOND) stockholders. Investors who purchased Sonder securities before March 16, 2023, are encouraged to participate in the investigation.

Portfolio Pulse from

January 06, 2025 | 3:15 pm

TSLA

Tesla (TSLA) has experienced its first annual decrease in car deliveries, leading to an analyst updating the stock's price target.

Portfolio Pulse from

January 06, 2025 | 3:15 pm

CRBU

Pomerantz Law Firm has filed a class action lawsuit against Caribou Biosciences, Inc. (NASDAQ:CRBU) and certain officers, alleging violations of federal securities laws. The lawsuit is on behalf of investors who acquired Caribou securities between July 14, 2023, and July 16, 2024.

Portfolio Pulse from

January 06, 2025 | 3:15 pm

HUMA

A securities fraud class action lawsuit is pending against Humacyte, Inc. (NASDAQ:HUMA). Investors who suffered losses are encouraged to contact Levi & Korsinsky before January 17, 2025, to discuss potential recovery options.

Portfolio Pulse from

January 06, 2025 | 3:15 pm